Frontiers in Hematology

Original Research

Published on 22 Nov 2024

Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia

in Blood Cancer

Somedeb Ball
Najla H. Al Ali
Akriti G. Jain
Luis E. Aguirre
Seongseok Yun
Onyee Chan
Zhuoer Xie
David A. Sallman
Jeffrey Lancet
Eric Padron

Frontiers in Hematology

doi 10.3389/frhem.2024.1492680

392 views

Case Report

Published on 13 Nov 2024

Case report: VEXAS syndrome and literature review

in Blood Cancer

Can Jones
Stanislav Ivanov
Pablo Ferraro
Souhad Younes
Hugo Fernandez

Frontiers in Hematology

doi 10.3389/frhem.2024.1480436

603 views

Mini Review

Accepted on 05 Nov 2024

Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults

in Blood Cancer

Linda Resar
Tania Jain

Frontiers in Hematology

doi 10.3389/frhem.2024.1483322

102 views

Review

Published on 29 Oct 2024

Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring

in Blood Cancer

Binsah George
Kok Hoe Chan
Adan Rios

Frontiers in Hematology

doi 10.3389/frhem.2024.1463410

2,106 views
1 citation

Perspective

Published on 18 Oct 2024

The CHIP-clinic as the catalyst of preventive medicine

in Blood Cancer

Hans Carl Hasselbalch
Vibe Skov
Lasse Kjaer
Trine Alma Knudsen
Christina Schjellerup Eickhardt-Dalbøge
Christina Ellervik
Sabrina Cordua
Anders Lindholm Sørensen
Sarah Friis Christensen
Marie Hvelplund Kristiansen

Frontiers in Hematology

doi 10.3389/frhem.2024.1459154

906 views

Review

Published on 07 Oct 2024

Clonal evolution: a landmark of MPN evolution

in Blood Cancer

Nabih Maslah
Stephane Giraudier
Bruno Cassinat
Jean-Jacques Kiladjian

Frontiers in Hematology

doi 10.3389/frhem.2024.1473920

1,026 views

Original Research

Published on 11 Sep 2024

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation

in Blood Cancer

Amalia Domingo-González
Rafael Alonso Fernández
Ana Jiménez
Teresa De Soto Álvarez
Ana Lerma-Verdejo
Virginia Pradillo
Gonzalo Benzo Callejo
Jose Sánchez-Pina
Elena Landete
Alberto Velasco-Valdazo

Frontiers in Hematology

doi 10.3389/frhem.2024.1438233

645 views

Editorial

Published on 14 Aug 2024

Editorial: Glycobiology in hematology: a promising avenue for cancer diagnostics and therapeutics

in Blood Cancer

Tao Zhang
Valerie R. Wiersma

Frontiers in Hematology

doi 10.3389/frhem.2024.1465473

699 views

Community Case Study

Published on 25 Jul 2024

Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study

in Blood Cancer

Barbara Loteta
Annalisa Pitino
Martina Pitea
Caterina Alati
Giovanni Tripepi
Maria Caterina Mico'
Maria Pellicano'
Francesca Cogliandro
Gaetana Porto
Giorgia Policastro

Frontiers in Hematology

doi 10.3389/frhem.2024.1441070

698 views

Mini Review

Published on 22 Jul 2024

Targeting the bone marrow niche, moving towards leukemia eradication

in Blood Cancer

Carla Semedo
Raquel Caroço
António Almeida
Bruno António Cardoso

Frontiers in Hematology

doi 10.3389/frhem.2024.1429916

1,650 views

Review

Published on 12 Jul 2024

Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets

in Blood Cancer

Cristian C. Taborda
Amer M. Zeidan
Lourdes M. Mendez

Frontiers in Hematology

doi 10.3389/frhem.2024.1419323

2,927 views
1 citation

Case Report

Published on 10 Jul 2024

Case report: Aggressive natural killer cell leukemia and refractory hemophagocytic lymphohistiocytosis in an adolescent

in Blood Cancer

Caroline Spaner
Jessica Durkee-Shock
Andrew Weng
Ryan Stubbins
Alina S. Gerrie
Stefania Pittaluga
Jeffrey I. Cohen
Luke Y. C. Chen

Frontiers in Hematology

doi 10.3389/frhem.2024.1413794

936 views

Review

Published on 08 Jul 2024

The sweet symphony of N-glycans in myeloid malignancies

in Blood Cancer

Javier Sanmartín-Martínez
Valerie R. Wiersma
Anna E. Marneth

Frontiers in Hematology

doi 10.3389/frhem.2024.1415618

783 views
1 citation

Original Research

Published on 20 Jun 2024

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

in Blood Cancer

Vittorio Del Fabro
Uros Markovic
Sara Frazzetto
Roberta Sciortino
Claudia Bellofiore
Mary Ann Di Giorgio
Valerio Leotta
Anna Bulla
Angelo Curto Pelle
Federica Elia

Frontiers in Hematology

doi 10.3389/frhem.2024.1425677

680 views

Brief Research Report

Published on 13 Jun 2024

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

in Blood Cancer

Theo Leitner
Cyrus Khandanpour
Knut Wendelin
Fuat Oduncu
Christoph Kimmich
Ralph Naumann
Miriam Kull
Hartmut Goldschmidt
Martin Ehmer
Claudia Kiewitz

Frontiers in Hematology

doi 10.3389/frhem.2024.1335161

758 views

Review

Published on 08 May 2024

AL amyloidosis: an overview on diagnosis, staging system, and treatment

in Blood Cancer

Sonia Morè
Valentina Maria Manieri
Laura Corvatta
Erika Morsia
Antonella Poloni
Massimo Offidani

Frontiers in Hematology

doi 10.3389/frhem.2024.1378451

2,392 views
1 citation